US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.89 ▼-1.02% TSLA $378.69 ▲+2.18% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% SNDK $1,704.16 ▼-0.92% AAPL $332.89 ▼-0.24%
FinancialContent

Microbot Medical Inc. - Common Stock (NQ:MBOT)

1.070 -0.090 (-7.76%)
Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Microbot Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Looking Into Microbot Medical's Recent Short Interest ↗
 
Via Benzinga
News headline image
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
All of the cash payable to the plaintiffs in the settlement will be covered by Microbot’s insurance carrier and will not impact company's cash position 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical study 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Gold Moves Lower; Microbot Medical Shares Slide ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The... 
Via Benzinga
Topics Stocks
News headline image
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet ↗
U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Friday. The Dow traded down 0.34% to 37,583.72 while the NASDAQ fell 0.73% to 14,984.98. The... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Gold Moves Lower; US Crude Stocks Decline Last Week ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90.... 
Via Benzinga
Topics Stocks
News headline image
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Down 1%; US Wholesale Inventories Fall In November ↗
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up 0.14% to 37,708.15 while the NASDAQ rose 0.19% to 15,127.17. The... 
Via Benzinga
Topics Stocks
News headline image
Microbot Medical Stock Is Moving Higher: What's Going On? ↗
Microbot Medical Inc (NASDAQ: MBOT) shares are trading higher Thursday after the company announced the completion of its GLP pivotal pre-cl 
Via Benzinga
News headline image
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular treatments 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
3 Stocks at the Forefront of Medical Robotics ↗
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid. 
Via InvestorPlace
News headline image
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase. 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
The V&V process is an additional key milestone toward regulatory submission and is required to continue the regulatory process with the FDA 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study
Follow up visual examination three days after the procedures using the LIBERTY Robotic Surgical System, confirms 100% success rate in reaching the targets with no adverse events 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial
The engagement is an additional step in the Company's path towards marketing clearance with the FDA 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket ↗
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday. 
Via Benzinga
News headline image
Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023
The presentation follows successful extensive uses of the Company’s endovascular robotic system in pre-clinical studies 
From Microbot Medical Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >